Valuation: Median Technologies

Market Cap 138M 155M 129M 117M 221M 14.91B 224M 1.56B 603M 7.6B 582M 569M 24.4B P/E 2026 *
-8.19x
P/E 2027 * -9.57x
Enterprise Value 155M 174M 145M 132M 248M 16.76B 251M 1.75B 677M 8.53B 653M 639M 27.41B EV / Sales 2026 *
6.08x
EV / Sales 2027 * 4.91x
Free-Float
97.93%
Yield 2026 *
-
Yield 2027 * -
1 week-5.01%
Current month-3.36%
1 month-14.59%
3 months-26.38%
6 months-21.23%
Current year-25.31%
1 week 3.45
Extreme 3.45
3.82
1 month 3.45
Extreme 3.45
4.41
3 years 1.17
Extreme 1.166
7.3
5 years 1.17
Extreme 1.166
17.46
Manager TitleAgeSince
Chief Executive Officer 64 31/12/2001
Director of Finance/CFO - 11/07/2021
Investor Relations Contact - 31/03/2019
Director TitleAgeSince
Chairman 64 31/12/2001
Chairman 64 09/04/2019
Director/Board Member 66 31/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-3.81%-5.01%+14.29%-22.66% 155M
-3.34%-3.81%+22.95%+28.91% 241B
-4.42%-5.37%-0.53%-14.65% 149B
-1.33%+0.43%-8.40%+37.27% 142B
-0.96%-3.25%-54.90%-18.12% 62.65B
-1.31%-0.63%+11.64%+22.96% 49.1B
-3.27%-3.56%+20.28%+49.06% 46.99B
+0.62%-0.13%-19.55%-21.49% 47.13B
-1.23%+2.58%-3.86%+38.57% 45.65B
-3.15%-1.11%+33.06%+55.18% 41.81B
Average -1.72%+0.29%+1.50%+15.50% 91.69B
Weighted average by Cap. -2.18%+0.45%+3.20%+18.69%

Financials

2026 *2027 *
Net sales 25.43M 28.63M 23.78M 21.67M 40.8M 2.76B 41.37M 288M 111M 1.4B 108M 105M 4.51B 33.43M 37.64M 31.27M 28.49M 53.64M 3.62B 54.38M 378M 146M 1.85B 141M 138M 5.93B
Net income -15.23M -17.15M -14.25M -12.98M -24.44M -1.65B -24.78M -172M -66.71M -841M -64.39M -63M -2.7B -11.23M -12.65M -10.51M -9.57M -18.02M -1.22B -18.27M -127M -49.2M -620M -47.48M -46.45M -1.99B
Net Debt 17M 19.14M 15.9M 14.49M 27.27M 1.84B 27.65M 192M 74.45M 939M 71.86M 70.3M 3.01B 26.5M 29.84M 24.78M 22.58M 42.52M 2.87B 43.1M 300M 116M 1.46B 112M 110M 4.7B
Logo Median Technologies
A pioneer in innovative imaging services and device software, Median Technologies (Median) leverages cutting-edge Artificial Intelligence (AI) technologies to increase the accuracy of early diagnosis and treatment of many cancers. Median's offerings, iCRO for the analysis and management of medical images in oncology clinical trials and eyonis® LCS, a suite of medical device software based on AI technologies, enable biopharmaceutical companies and clinicians to advance patient care and accelerate the development of new therapies. Median is also present in the United States and China.
Employees
-
Date Price Change
02/10/26 €3.450 -4.17%
01/10/26 €3.600 -3.36%
30/09/26 €3.725 +0.40%
29/09/26 €3.710 -1.85%
28/09/26 €3.780 -0.79%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.605EUR
Average target price
11.97EUR
Spread / Average Target
+231.95%

Annual profits - Rate of surprise